DOI QR코드

DOI QR Code

Endovascular Therapy for Complex Iliac Lesions: There Is Much More to Be Defined

  • Yahya Alansari (Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Pil Hyung Lee (Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2022.05.13
  • Accepted : 2022.05.17
  • Published : 2022.07.01

Abstract

Keywords

References

  1. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67. https://doi.org/10.1016/j.jvs.2006.12.037
  2. Leville CD, Kashyap VS, Clair DG, et al. Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients. J Vasc Surg 2006;43:32-9. https://doi.org/10.1016/j.jvs.2005.09.034
  3. Kim DY, Ko YG, Lee SJ, et al. Korean multicenter registry study of EPIC stents for the treatment of iliac artery disease: K-EPIC Registry. Korean Circ J 2021;51:441-51. https://doi.org/10.4070/kcj.2020.0420
  4. Roh JW, Shin S, Ko YG, et al. Long-term clinical outcomes of iliac artery endovascular therapy in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry. Korean Circ J 2022;52:529-40. https://doi.org/10.4070/kcj.2021.0390
  5. de Donato G, Bosiers M, Setacci F, et al. 24-month data from the BRAVISSIMO: a large-scale prospective registry on iliac stenting for TASC A & B and TASC C & D lesions. Ann Vasc Surg 2015;29:738-50. https://doi.org/10.1016/j.avsg.2014.12.027
  6. Premaratne S, Newman J, Hobbs S, Garnham A, Wall M. Meta-analysis of direct surgical versus endovascular revascularization for aortoiliac occlusive disease. J Vasc Surg 2020;72:726-37. https://doi.org/10.1016/j.jvs.2019.12.035
  7. Ko YG, Ahn CM, Min PK, et al. Baseline characteristics of a retrospective patient cohort in the Korean Vascular Intervention Society Endovascular Therapy in Lower Limb Artery Diseases (K-VIS ELLA) Registry. Korean Circ J 2017;47:469-76. https://doi.org/10.4070/kcj.2017.0020
  8. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa S. 15-year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv 2015;8:1893-901. https://doi.org/10.1016/j.jcin.2015.08.020
  9. Krankenberg H, Zeller T, Ingwersen M, et al. Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial. JACC Cardiovasc Interv 2017;10:1694-704. https://doi.org/10.1016/j.jcin.2017.05.015
  10. Cha JJ, Kim JY, Kim H, et al. Long-term clinical outcomes and prognostic factors after endovascular treatment in patients with chronic limb threatening ischemia. Korean Circ J 2022;52:429-40. https://doi.org/10.4070/kcj.2021.0342